key: cord-0836359-k3qp2lxc
authors: Mwenda, Mulenga; Saasa, Ngonda; Sinyange, Nyambe; Busby, George; Chipimo, Peter J.; Hendry, Jason; Kapona, Otridah; Yingst, Samuel; Hines, Jonas Z.; Minchella, Peter; Simulundu, Edgar; Changula, Katendi; Nalubamba, King Shimumbo; Sawa, Hirofumi; Kajihara, Masahiro; Yamagishi, Junya; Kapin’a, Muzala; Kapata, Nathan; Fwoloshi, Sombo; Zulu, Paul; Mulenga, Lloyd B.; Agolory, Simon; Mukonka, Victor; Bridges, Daniel J.
title: Detection of B.1.351 SARS-CoV-2 Variant Strain — Zambia, December 2020
date: 2021-02-26
journal: MMWR Morb Mortal Wkly Rep
DOI: 10.15585/mmwr.mm7008e2
sha: 74740bb7979623412bb9aa215bb7284c68d03fad
doc_id: 836359
cord_uid: k3qp2lxc

The first laboratory-confirmed cases of coronavirus disease 2019 (COVID-19), the illness caused by SARS-CoV-2, in Zambia were detected in March 2020 (1). Beginning in July, the number of confirmed cases began to increase rapidly, first peaking during July-August, and then declining in September and October (Figure). After 3 months of relatively low case counts, COVID-19 cases began rapidly rising throughout the country in mid-December. On December 18, 2020, South Africa published the genome of a SARS-CoV-2 variant strain with several mutations that affect the spike protein (2). The variant included a mutation (N501Y) associated with increased transmissibility.†,§ SARS-CoV-2 lineages with this mutation have rapidly expanded geographically.¶,** The variant strain (PANGO [Phylogenetic Assignment of Named Global Outbreak] lineage B.1.351††) was first detected in the Eastern Cape Province of South Africa from specimens collected in early August, spread within South Africa, and appears to have displaced the majority of other SARS-CoV-2 lineages circulating in that country (2). As of January 10, 2021, eight countries had reported cases with the B.1.351 variant. In Zambia, the average number of daily confirmed COVID-19 cases increased 16-fold, from 44 cases during December 1-10 to 700 during January 1-10, after detection of the B.1.351 variant in specimens collected during December 16-23. Zambia is a southern African country that shares substantial commerce and tourism linkages with South Africa, which might have contributed to the transmission of the B.1.351 variant between the two countries.

On February 17, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr).

The first laboratory-confirmed cases of coronavirus disease 2019 (COVID-19), the illness caused by SARS-CoV-2, in Zambia were detected in March 2020 (1) . Beginning in July, the number of confirmed cases began to increase rapidly, first peaking during July-August, and then declining in September and October (Figure) . After 3 months of relatively low case counts, COVID-19 cases began rapidly rising throughout the country in mid-December. On December 18, 2020, South Africa published the genome of a SARS-CoV-2 variant strain with several mutations that affect the spike protein (2) . The variant included a mutation (N501Y) associated with increased transmissibility. †, § SARS-CoV-2 lineages with this mutation have rapidly expanded geographically. ¶, ** The variant strain (PANGO [Phylogenetic Assignment of Named Global Outbreak] lineage B.1.351 † † ) was first detected in the Eastern Cape Province of South Africa from specimens collected in early August, spread within South Africa, and appears to have displaced the majority of other SARS-CoV-2 lineages circulating in that country (2) . As of January 10, 2021, eight countries had reported cases with the B.1.351 variant. In Zambia, the average number of daily confirmed COVID-19 cases increased 16-fold, from 44 cases during December 1-10 to 700 during January 1-10, after detection of the B.1.351 variant in specimens collected during December 16-23. Zambia is a southern African country that shares substantial commerce and tourism linkages with South Africa, which might have contributed to the transmission of the B.1.351 variant between the two countries.

Since September 2020, University of Zambia and PATH (https://www.path.org) have routinely been conducting genetic epidemiologic studies using whole genome sequencing (WGS) on SARS-CoV-2-positive specimens. A subset of * These authors contributed equally to this work. † https://khub.net/documents/135939561/338928724/SARS-CoV-2%20 variant%20under%20investigation,%20meeting%20minutes. pdf/962e866b-161f-2fd5-1030-32b6ab467896?t = 1608470511452 § https://virological.org/t/mutations-arising-in-sars-cov-2-spike-on-sustainedhuman-to-human-transmission-and-human-to-animal-passage/578 ¶ https://cmmid.github.io/topics/covid19/uk-novel-variant.html ** https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/ † † https://github.com/cov-lineages/pangolin/ and deaths.*** The B.1.351 variant might be associated with higher viral loads and contains another spike protein mutation (E484K) that might hinder antibody binding, † † †, § § § which could blunt naturally developed immunity or reduce vaccine efficacy. The predominance of the B.1.351 variant in a small cohort of recent specimens suggests that it might have become the dominant lineage in Zambia, although additional WGS of specimens from other districts is needed to characterize the full extent of its spread. Further, the available genomic data could not identify when and from where the B. All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Edgar Simulundu reports receipt of reagents from Hokkaido University during the course of the study. No other potential conflicts of interest were disclosed.

First 100 persons with COVID-19-Zambia

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv

First COVID-19 case in Zambia-comparative phylogenomic analyses of SARS-CoV-2 detected in African countries